Olema Pharmaceuticals Inc...

NASDAQ: OLMA · Real-Time Price · USD
5.52
0.26 (4.94%)
At close: Aug 15, 2025, 3:59 PM
5.54
0.36%
After-hours: Aug 15, 2025, 06:03 PM EDT

Olema Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 364K n/a n/a n/a 1.88M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 128K 182K 95K 94K 88K 88K 90K 425K 427K 423K 418K 410K 407K 1.57M 50K 31K 9K
Gross Profit
n/a -128K 182K -95K -94K -88K 1.8M -90K -425K -427K -423K -418K -410K -407K -1.57M -50K -31K -9K
Operating Income
-47.86M -34.87M -36.77M -37.62M -33.53M -34.34M -30.42M -23.34M -21.6M -29.6M -27.22M -23.22M -33.29M -23.25M -21.76M -17.76M -16.52M -15.45M
Interest Income
4.04M 4.52M 3.29M 2.93M 3.11M 3.35M 3.55M 1.92M 1.55M 1.3M 973K 622K 415K 218K 109K 105K 117K 111K
Pretax Income
-43.78M -30.39M -33.57M -34.55M -30.38M -30.97M -26.77M -21.5M -20.09M -28.29M -26.18M -22.72M -32.86M -23.03M -21.64M -17.71M -16.41M -15.34M
Net Income
-43.78M -30.39M -33.57M -34.55M -30.38M -30.97M -26.77M -21.5M -20.09M -26.97M -25.14M -22.22M -32.86M -22.81M -21.64M -17.71M -16.41M -15.34M
Selling & General & Admin
3.96M 4.25M 4.47M 4.39M 4.42M 4.46M 4.46M 3.89M 3.61M 6.78M 5.63M 5.59M 6.24M 7.25M 5.78M 5.24M 4.61M 4.76M
Research & Development
43.9M 30.62M 32.3M 33.23M 29.11M 29.88M 25.87M 19.45M 17.99M 22.83M 21.58M 17.63M 27.05M 16.01M 15.97M 12.52M 11.91M 10.69M
Other Expenses
n/a n/a n/a n/a n/a 17K 93K -79K -44K 11K 67K -120K 20K 6K 10K -56K -1K n/a
Operating Expenses
47.86M 34.87M 36.77M 37.62M 33.53M 34.34M 30.33M 23.34M 21.6M 29.6M 27.22M 23.22M 33.29M 23.25M 21.76M 17.76M 16.52M 15.45M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -88K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
47.86M 34.87M 36.95M 37.62M 33.53M 34.34M 30.42M 23.34M 21.6M 29.6M 27.22M 23.22M 33.29M 23.25M 21.76M 17.76M 16.52M 15.45M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.32M -1.04M -502K n/a -224K -63K -56K -1K 111K
Shares Outstanding (Basic)
85.5M 85.43M 58.74M 57.26M 56.28M 55.57M 54.78M 44.98M 40.72M 40.35M 40.19M 40.04M 39.92M 39.83M 39.74M 39.61M 39.42M 39.33M
Shares Outstanding (Diluted)
85.5M 85.43M 58.74M 57.26M 56.28M 55.57M 54.78M 44.98M 40.72M 40.35M 40.19M 40.04M 39.92M 39.83M 39.74M 39.61M 39.42M 39.33M
EPS (Basic)
-0.51 -0.36 -0.57 -0.6 -0.54 -0.56 -0.49 -0.48 -0.49 -0.67 -0.63 -0.55 -0.82 -0.57 -0.54 -0.45 -0.42 -0.39
EPS (Diluted)
-0.51 -0.36 -0.57 -0.6 -0.54 -0.56 -0.49 -0.48 -0.49 -0.67 -0.63 -0.55 -0.82 -0.57 -0.54 -0.45 -0.42 -0.39
EBITDA
-47.86M -34.74M -36.65M -37.53M -33.44M -34.25M -30.33M -23.25M -21.5M -29.6M -27.12M -23.13M -33.21M -23.17M -21.57M -17.71M -16.49M -15.44M
EBIT
-43.78M -34.87M -36.77M -37.62M -33.53M -34.34M -30.42M -23.34M -21.6M -29.6M -27.22M -23.22M -33.29M -23.25M -21.64M -17.76M -16.52M -15.45M
Depreciation & Amortization
n/a 128K 116K 95K 94K 88K 88K 90K 425K 427K 423K 418K 410K 407K 1.57M 50K 31K 9K